Cardigan Completes Enrollment in Phase 2b Off-Catalyst Trial and Announces New Evidence Supporting Patient Selection and Endpoints for Evaluation of Ataciguat in Aortic Stenosis -. Company announcement.
🇵🇪 פרו · לימה · Map
Cardigan Completes Enrollment in Phase 2b Off-Catalyst Trial and Announces New Evidence Supporting Patient Selection and Endpoints for Evaluation of Ataciguat in Aortic Stenosis -. Company announcement.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in